Business
Humana Reports Second Quarter 2025 Financial Results; Raises Full Year 2025 Adjusted EPS and Revenue Guidance
LOUISVILLE, Ky., July 30, 2025--Humana Inc. (NYSE: HUM) today reported consolidated pretax results and diluted earnings per share (EPS) for the quarter ended June 30, 2025 (2Q25) versus the quarter ended June 30, 2024 (2Q24) and for the six months ended June 30, 2025 (YTD 2025) versus the six months ended June 30, 2024 (YTD 2024) as noted in the tables below.
About this update from Humana Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/29e1bf76b22dec619380450de4f38cec"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6furvHzXZAvA0WM.v_fE7w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/29e1bf76b22dec619380450de4f38cec","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/oiWq9yZoNtxAm5ug1Duq1w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/29e1bf76b22dec619380450de4f38cec","width":1024,"height":512}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Reports 2Q25 earnings per share (EPS) of $4.51 on a GAAP basis, Adjusted EPS of $6.27; reports YTD EPS of $14.81 on a GAAP basis, $17.85 on an Adjusted basis","length":157,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"2Q25 Insurance segment benefit ratio of 89.9 percent, in line with the company's previously disclosed expectation of 'approximately 90 percent'","length":155,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Updates FY 2025 GAAP EPS guidance to 'approximately $13.77' from the previous estimate of 'approximately $14.68'; raises Adjusted FY 2025 EPS guidance to 'approximately $17.00', up from the previous 'approximately $16.25' guidance","length":262,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Raises FY 2025 consolidated revenues guidance to 'at least $128 billion' compared to the previous guidance range of $126 billion to $128 billion","length":152,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Affirms FY 2025 Insurance segment benefit ratio guidance range of 90.1 percent to 90.5 percent","length":94,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Revises FY 2025 individual Medicare Advantage membership guidance to now anticipate a decline of 'up to 500,000 members' from previous guidance of a decline of 'approximately 550,000'","length":199,"tagName":"p","attribs":{}},{"type":"list","items":[{"val":[{"type":"text","content":"Expected membership decline inclusive of the impact of exiting certain unprofita...